NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 100 filers reported holding NUVALENT INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,350,625 | -44.6% | 812,500 | -49.2% | 0.58% | -36.3% |
| Q2 2023 | $67,472,000 | +36.9% | 1,600,000 | -15.3% | 0.92% | +25.2% |
| Q1 2023 | $49,281,088 | +6.4% | 1,888,888 | +21.4% | 0.73% | +5.6% |
| Q4 2022 | $46,324,428 | +127.1% | 1,555,555 | +48.2% | 0.69% | +83.6% |
| Q3 2022 | $20,402,000 | +43.4% | 1,049,471 | 0.0% | 0.38% | +34.2% |
| Q2 2022 | $14,231,000 | -2.4% | 1,049,471 | 0.0% | 0.28% | +5.6% |
| Q1 2022 | $14,577,000 | -20.9% | 1,049,471 | -4.8% | 0.27% | -15.3% |
| Q4 2021 | $18,431,000 | -17.3% | 1,102,671 | -12.3% | 0.31% | -10.3% |
| Q3 2021 | $22,288,000 | – | 1,257,671 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,884,492 | $75,256,396 | 12.94% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $93,331 | 11.66% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $521,565,816 | 11.63% |
| COMMODORE CAPITAL LP | 1,075,000 | $28,046,750 | 4.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 281,533 | $7,345,196 | 3.03% |
| Perceptive Advisors | 2,300,048 | $60,008,252 | 1.77% |
| Boxer Capital, LLC | 1,210,192 | $31,574 | 1.55% |
| Avoro Capital Advisors LLC | 1,888,888 | $49,281,088 | 0.73% |
| Soleus Capital Management, L.P. | 236,900 | $6,180,721 | 0.64% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,402,525 | $36,591,877 | 0.51% |